Nutrien (NTR) declares $0.545/share quarterly dividend, in line with previous. Forward yield 4.04% Payable Jan. 16; for ...

In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Gavin Newsom, Anna Wintour, Doja Cat and a handful of Hollywood stars came to celebrate Tinseltown and all its fashion.

Minister Nzimande’s address at BIO Africa-CPHIA 2025 is more than a policy speech—it is a strategic call to action for Africa ...

Major stock indexes rose Thursday, as investors digested the latest batch of corporate earnings and China trade news.

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Every investor knows the reflex. You see the words reverse split, and your instincts flinch. It's practically Pavlovian. But sometimes, what looks ...

Pfizer Inc. (NYSE:PFE) strengthens its global pharmaceutical leadership and research presence in the S&P 500 Index.

Saudi Arabia’s benchmark Tadawul All Share Index (TASI) fell 0.8%, or more than 100 points, to below 11,300 points after opening today, Nov. 5. Argaam Investment Company has updated the Privacy Policy ...

Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.